ReproCELL Incorporated
4978
Rank in Stocks
#21326
Established in 2003 and headquartered in Yokohama, Japan, ReproCELL... Established in 2003 and headquartered in Yokohama, Japan, ReproCELL Incorporated operates as a prominent firm specializing in stem cell research. The company furnishes an extensive portfolio of products crucial for various stem cell applications, including a diverse array of specialized reagents for RNA reprogramming, cell growth (such as small molecules, growth factors, and cytokines), cell characterization (like antibodies and staining kits), cell culture (including pluripotent stem cell media and cell substrates), and cell handling (such as cryopreservation media, dissociation solutions, and transfection reagents). Furthermore, ReproCELL provides differentiated induced pluripotent stem cells (iPSCs), related components like feeder cells and induced neurons, 3D cell culture systems, and general laboratory consumables. Complementing its product lines, the company offers a comprehensive suite of services, spanning preclinical genomics, dedicated stem cell research, drug development support (encompassing efficacy, safety, and ADME analyses), access to human tissue samples, therapeutic pipeline development, and a range of clinical services, including laboratory diagnostics and the creation of GMP iPSC master cell banks.
Share Price
$0.6816057
Last synced: 2026-11-13
Market Cap
$68.94M
Change (1 day)
-0.12%
Change (1 year)
-32.62%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ReproCELL Incorporated (4978)
Category
Healthcare
EPS for ReproCELL Incorporated (4978)
EPS as of September 2026 TTM: $-0.03
According to ReproCELL Incorporated's latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $0.01, an increase over its 2024 EPS of 0.00.
EPS history for ReproCELL Incorporated from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -372.00% |
| 2025 | $0.01 | -408.33% |
| 2024 | 0.00 | -91.21% |
| 2023 | $-0.03 | -56.11% |
| 2022 | $-0.06 | -39.44% |
| 2021 | $-0.10 | -22.61% |
| 2020 | $-0.13 | 67.55% |
| 2019 | $-0.08 | -75.45% |
| 2018 | $-0.32 | 129.12% |
| 2017 | $-0.14 | -56.19% |
| 2016 | $-0.32 | 327.96% |
| 2015 | $-0.08 | 151.17% |
| 2014 | $-0.03 | -1,968.75% |
| 2013 | 0.00 | -122.86% |
| 2012 | $-0.01 | -36.36% |
| 2011 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 3,172.06% |
US
|
|
| $15.66 | -57,673.53% |
US
|
|
| $-7.07 | 25,892.65% |
US
|
|
| $-5.29 | 19,348.53% |
AU
|
|
| $12.73 | -46,909.56% |
BE
|
Questions about ReproCELL Incorporated's earnings per share (EPS)
What is ReproCELL Incorporated's earnings per share (EPS)?
ReproCELL Incorporated's earnings per share (EPS) over the last twelve months is $-0.03, as of Sep 2026.
What was ReproCELL Incorporated's earnings per share (EPS) in 2025?
In 2025, ReproCELL Incorporated's earnings per share (EPS) was $0.01, compared with 0.00 in 2024.
How has ReproCELL Incorporated's earnings per share (EPS) changed since 2020?
From 2020 to 2025, ReproCELL Incorporated's earnings per share (EPS) was highest in 2025 ($0.01) and lowest in 2020 ($-0.13).
How does ReproCELL Incorporated's earnings per share (EPS) compare with similar companies?
ReproCELL Incorporated's earnings per share (EPS) ($-0.03) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.